
Ubachukwu A. Odunukwe
Examiner (ID: 1321, Phone: (571)272-8927 , Office: P/2654 )
| Most Active Art Unit | 2654 |
| Art Unit(s) | 2654 |
| Total Applications | 314 |
| Issued Applications | 254 |
| Pending Applications | 0 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18267129
[patent_doc_number] => 20230088371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST
[patent_app_type] => utility
[patent_app_number] => 17/948550
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948550 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST | Sep 19, 2022 | Pending |
Array
(
[id] => 18267129
[patent_doc_number] => 20230088371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST
[patent_app_type] => utility
[patent_app_number] => 17/948550
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948550 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST | Sep 19, 2022 | Pending |
Array
(
[id] => 19049221
[patent_doc_number] => 20240091190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SKIN CREAM FOR REDUCING BED SORES
[patent_app_type] => utility
[patent_app_number] => 17/946067
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946067 | SKIN CREAM FOR REDUCING BED SORES | Sep 15, 2022 | Abandoned |
Array
(
[id] => 18784825
[patent_doc_number] => 20230372475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => STABILIZATION OF ANTIGENS FOR LONG TERM ADMINISTRATION IN TRANSDERMAL MICRONEEDLE PATCHES
[patent_app_type] => utility
[patent_app_number] => 18/247962
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247962 | STABILIZATION OF ANTIGENS FOR LONG TERM ADMINISTRATION IN TRANSDERMAL MICRONEEDLE PATCHES | Sep 1, 2022 | Pending |
Array
(
[id] => 18784825
[patent_doc_number] => 20230372475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => STABILIZATION OF ANTIGENS FOR LONG TERM ADMINISTRATION IN TRANSDERMAL MICRONEEDLE PATCHES
[patent_app_type] => utility
[patent_app_number] => 18/247962
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247962 | STABILIZATION OF ANTIGENS FOR LONG TERM ADMINISTRATION IN TRANSDERMAL MICRONEEDLE PATCHES | Sep 1, 2022 | Pending |
Array
(
[id] => 18254640
[patent_doc_number] => 20230081679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SURFACTANT VESICLES FOR VACCINE FORMULATION, TARGETED DRUG DELIVERY, AND TRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 17/929630
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929630 | SURFACTANT VESICLES FOR VACCINE FORMULATION, TARGETED DRUG DELIVERY, AND TRANSFECTION | Sep 1, 2022 | Abandoned |
Array
(
[id] => 18255039
[patent_doc_number] => 20230082078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SODIUM BICARBONATE NUTRITIONAL SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/893880
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893880 | SODIUM BICARBONATE NUTRITIONAL SUPPLEMENT | Aug 22, 2022 | Pending |
Array
(
[id] => 18255039
[patent_doc_number] => 20230082078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SODIUM BICARBONATE NUTRITIONAL SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/893880
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893880 | SODIUM BICARBONATE NUTRITIONAL SUPPLEMENT | Aug 22, 2022 | Pending |
Array
(
[id] => 18434165
[patent_doc_number] => 20230181459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/891061
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891061 | TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS | Aug 17, 2022 | Pending |
Array
(
[id] => 18434165
[patent_doc_number] => 20230181459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/891061
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891061 | TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS | Aug 17, 2022 | Pending |
Array
(
[id] => 19098127
[patent_doc_number] => 20240117355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => LIPOPROTEIN-MIMICKING SOLID LIPID NANOPARTICLES FOR DRUG DELIVERY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018986
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018986 | LIPOPROTEIN-MIMICKING SOLID LIPID NANOPARTICLES FOR DRUG DELIVERY AND USES THEREOF | May 22, 2022 | Pending |
Array
(
[id] => 17790281
[patent_doc_number] => 20220249372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell
[patent_app_type] => utility
[patent_app_number] => 17/727956
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727956 | Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell | Apr 24, 2022 | Pending |
Array
(
[id] => 20315266
[patent_doc_number] => 12453805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
[patent_app_type] => utility
[patent_app_number] => 17/700950
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 55
[patent_no_of_words] => 16740
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700950 | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery | Mar 21, 2022 | Issued |
Array
(
[id] => 17849738
[patent_doc_number] => 20220279779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => LIQUID HERBICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/687179
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687179 | LIQUID HERBICIDAL COMPOSITIONS | Mar 3, 2022 | Pending |
Array
(
[id] => 17849740
[patent_doc_number] => 20220279781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PROCESS FOR PRODUCING A LIQUID HERBICIDAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/687001
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687001 | PROCESS FOR PRODUCING A LIQUID HERBICIDAL COMPOSITION | Mar 3, 2022 | Pending |
Array
(
[id] => 17849738
[patent_doc_number] => 20220279779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => LIQUID HERBICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/687179
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687179 | LIQUID HERBICIDAL COMPOSITIONS | Mar 3, 2022 | Pending |
Array
(
[id] => 18535903
[patent_doc_number] => 20230240989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => LIPOSOMAL OZONE NANOSOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 18/004973
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004973
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004973 | LIPOSOMAL OZONE NANOSOLUTIONS | Feb 28, 2022 | Abandoned |
Array
(
[id] => 18649393
[patent_doc_number] => 20230295199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => PHOSPHOLIPID
[patent_app_type] => utility
[patent_app_number] => 18/017751
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017751
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017751 | PHOSPHOLIPID | Feb 28, 2022 | Pending |
Array
(
[id] => 17532325
[patent_doc_number] => 20220110934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/645509
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/645509 | PHARMACEUTICAL COMPOSITION | Dec 21, 2021 | Abandoned |
Array
(
[id] => 18970271
[patent_doc_number] => 20240050363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => VILAZODONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/259140
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259140 | VILAZODONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Dec 19, 2021 | Pending |